Guro E. Lind

Publications by Guro Elisabeth Lind

40 publications found

Publications in press

1. Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA
   ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
   Gut (in press)
   PubMed 22213796
2. Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, Rivedal E
   Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
   Int J Cancer (in press)
   PubMed 21866551
3. Sveen A, Bakken AC, Agesen TH, Lind GE, Nesbakken A, Nordgård O, Brackmann S, Rognum TO, Lothe RA, Skotheim RI
   The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer
   Int J Cancer (in press)
   PubMed 22173985

Publications 2012

1. Paulo P, Barros-Silva JD, Ribeiro FR, Ramalho-Carvalho J, Jerónimo C, Henrique R, Lind GE, Skotheim RI, Lothe RA, Teixeira MR (2012)
   FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer
   Genes Chromosomes Cancer, 51 (3), 240-9
   PubMed 22081504

Publications 2011

1. Ahmed D, Lothe RA, Rivedal E, Lind GE (2011)
   Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors
   Endocr Relat Cancer, 18 (6), C31-4
   PubMed 21868474
2. Alagaratnam S, Lind GE, Kraggerud SM, Lothe RA, Skotheim RI (2011)
   The testicular germ cell tumour transcriptome
   Int J Androl, 34 (4 Pt 2), e133-50; discussion e150-1
   PubMed 21651573
3. Boberg KM, Lind GE (2011)
   Primary sclerosing cholangitis and malignancy
   Best Pract Res Clin Gastroenterol, 25 (6), 753-64
   PubMed 22117640
4. Costa VL, Henrique R, Danielsen SA, Eknaes M, Patrício P, Morais A, Oliveira J, Lothe RA, Teixeira MR, Lind GE, Jerónimo C (2011)
   TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers
   Epigenetics, 6 (9), 1120-1130
   PubMed 21847011
5. Danielsen SA, Cekaite L, Ågesen TH, Sveen A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE, Lothe RA (2011)
   Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
   PLoS One, 6 (9), e24419
   PubMed 21909432
6. Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, Bretthauer M, Thiis-Evensen E, Nesbakken A, Lothe RA (2011)
   Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
   Mol Cancer, 10, 85
   PubMed 21777459
7. Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H, Lothe RA (2011)
   SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
   Oncogene, 30 (37), 3967-78
   PubMed 21499309
8. Løvf M, Thomassen GO, Bakken AC, Celestino R, Fioretos T, Lind GE, Lothe RA, Skotheim RI (2011)
   Fusion gene microarray reveals cancer type-specificity among fusion genes
   Genes Chromosomes Cancer, 50 (5), 348-57
   PubMed 21305644
9. Ribeiro FR, Paulo P, Costa VL, Barros-Silva JD, Ramalho-Carvalho J, Jerónimo C, Henrique R, Lind GE, Skotheim RI, Lothe RA, Teixeira MR (2011)
   Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene
   PLoS One, 6 (7), e22317
   PubMed 21814574
10. Sirnes S, Honne H, Ahmed D, Danielsen SA, Rognum TO, Meling GI, Leithe E, Rivedal E, Lothe RA, Lind GE (2011)
    DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (Connexin45) by promoter hypermethylation in colorectal cancer
    Epigenetics, 6 (5), 602-9
    PubMed 21406965
11. Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
    CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
    Genes Immun, 12 (8), 653-62
    PubMed 21716316

Publications 2010

1. Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA (2010)
   Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
   J Clin Oncol, 28 (9), 1573-82
   PubMed 20159821
2. Costa VL, Henrique R, Danielsen SA, Duarte-Pereira S, Eknaes M, Skotheim RI, Rodrigues A, Magalhães JS, Oliveira J, Lothe RA, Teixeira MR, Jerónimo C, Lind GE (2010)
   Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples
   Clin Cancer Res, 16 (23), 5842-51
   PubMed 20975101
3. Pinheiro M, Ahlquist T, Danielsen SA, Lind GE, Veiga I, Pinto C, Costa V, Afonso L, Sousa O, Fragoso M, Santos L, Henrique R, Lopes P, Lopes C, Lothe RA, Teixeira MR (2010)
   Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin
   BMC Cancer, 10, 587
   PubMed 20979647
4. Zwierzina H, Bardelli A, Ciardiello F, Gariboldi M, Håkansson L, Lambrechts D, Lind GE, Loeffler-Ragg J, Schmoll H, Siena S, Tabernero J, Van Cutsem E (2010)
   Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials
   Curr Opin Mol Ther, 12 (6), 703-11
   PubMed 21154162

Publications 2009

1. Danielsen SA, Lind GE, Biornslett M, Meling GI, Rognum TO, Heim S, Lothe RA (2009)
   Novel Mutations of the Suppressor Gene PTEN in Colorectal Carcinomas Stratified by Microsatellite Instability- and TP53 Mutation- Status (vol 29, pg E252, 2008)
   Hum. Mutat., 30 (6), 1023
2. Skotheim RI, Thomassen GO, Eken M, Lind GE, Micci F, Ribeiro FR, Cerveira N, Teixeira MR, Heim S, Rognes T, Lothe RA (2009)
   A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
   Mol Cancer, 8, 5
   PubMed 19152679

Publications 2008

1. Ahlquist T, Bottillo I, Danielsen SA, Meling GI, Rognum TO, Lind GE, Dallapiccola B, Lothe RA (2008)
   RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
   Neoplasia, 10 (7), 680-6, 2 p following 686
   PubMed 18592002
2. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA (2008)
   Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
   Mol Cancer, 7, 94
   PubMed 19117505
3. Danielsen SA, Lind GE, Bjørnslett M, Meling GI, Rognum TO, Heim S, Lothe RA (2008)
   Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status
   Hum Mutat, 29 (11), E252-62
   PubMed 18781614
4. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO, Thiis-Evensen E, Lothe RA (2008)
   Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
   J Transl Med, 6, 13
   PubMed 18346269

Publications 2007

1. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, Nesland JM, Myklebost O, Rognum TO, Giercksky KE, Skotheim RI, Lothe RA (2007)
   Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
   Mol Cancer, 6, 2
   PubMed 17201907
2. Lind GE, Ahlquist T, Lothe RA (2007)
   DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors
   Gastroenterology, 132 (4), 1631-2; author reply 1632
   PubMed 17408629
3. Lind GE, Skotheim RI, Lothe RA (2007)
   The epigenome of testicular germ cell tumors
   APMIS, 115 (10), 1147-60
   PubMed 18042148
4. Wu Q, Lind GE, Aasheim HC, Micci F, Silins I, Tropé CG, Nesland JM, Lothe RA, Suo Z (2007)
   The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers
   Epigenetics, 2 (4), 237-43
   PubMed 18281782
5. Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007)
   DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
   Mol Cancer, 6, 45
   PubMed 17623056

Publications 2006

1. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
   ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
   Cell Oncol, 28 (5-6), 259-72
   PubMed 17167179
2. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Esteller M, Lothe RA (2006)
   Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1)
   J Pathol, 210 (4), 441-9
   PubMed 17029216
3. Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O, Kallioniemi O, Lothe RA (2006)
   Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes
   Cell Oncol, 28 (5-6), 315-26
   PubMed 17167184

Publications 2005

1. Agesen TH, Flørenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, Komdeur R, Myklebost O, van den Berg E, Lothe RA (2005)
   Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors
   J Neuropathol Exp Neurol, 64 (1), 74-81
   PubMed 15715087
2. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Henrique R, Saatcioglu F, Esteller M, Teixeira MR, Lothe RA (2005)
   The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation
   Mol Cancer, 4 (1), 8
   PubMed 15691383
3. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA (2005)
   Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
   Cancer Res, 65 (13), 5588-98
   PubMed 15994931
4. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL (2005)
   Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis
   Methods Mol Biol, 291, 207-16
   PubMed 15502225
5. Thorstensen L, Lind GE, Løvig T, Diep CB, Meling GI, Rognum TO, Lothe RA (2005)
   Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability
   Neoplasia, 7 (2), 99-108
   PubMed 15802015

Publications 2004

1. Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA (2004)
   A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
   Mol Cancer, 3, 28
   PubMed 15476557

Publications 2002

1. Smith-Sørensen B, Lind GE, Skotheim RI, Fosså SD, Fodstad Ø, Stenwig AE, Jakobsen KS, Lothe RA (2002)
   Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
   Oncogene, 21 (57), 8878-84
   PubMed 12483540